News

Michael Sydes outlines some strategies that CRA's can use to maintain good clinical practices.

This article will address concerns and look at how the pragmatic implementation of surveys in today’s clinical trials can provide valuable insight into patient satisfaction levels, motivators, likelihood to follow study requirements and information retention.

As part of efforts to speed patient access to effective new therapies, FDA is rolling out policies designed to streamline drug development, particularly for new cancer therapies to treat life-threatening conditions.

Updated employee announcements, business news, awards, and recognition in the industry today.

Small and medium-sized businesses are seeking clarification on how the new ICH E6 guidelines will impact their business.

In this article, Moe will elaborate on how to run an effective and engaging social media campaign on Facebook.

It is time for mandatory certification to be required for everyone involved in a clinical study.

AMPLEXOR’s Dana Weiss explains the critical role of linguistic validation in enabling the patients voice.

Machine learning algorithms can be used to both manage the complex outputs in clinical trials and make those trials move faster with less risk, reducing timelines, and minimizing expenses.

CBI, the conference group sister of Applied Clinical Trials, is featuring their Global Risk Based Monitoring Conference in September.

This article will examine the ways to detect fraud and data fabrication within a clinical trial.

With looming workforce loss-now much higher than first anticipated-prompting further cutback plans at EMA, the threat to drug developers, suppliers, and patients is intensifying.

Looking beyond the hype to see how innovations such as data, techniques, and technology can be brought together to improve the lives of patients.